Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current BD1 market cap is 109.21M. The company's latest EPS is AUD -0.0621 and P/E is -7.41.
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 71k | 1.43M | 2M | 1.55M | 1.56M |
| Operating Income | -3.36M | -13.86M | -20.32M | -9.32M | -6.77M |
| Net Income | -3.25M | -11.15M | -18.2M | -8.97M | -6.55M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 7.37M | 33.52M | 30.78M | 21.51M | 21.71M |
| Total Liabilities | 899k | 4.47M | 2.49M | 1.89M | 1.72M |
| Total Equity | 6.48M | 29.06M | 28.29M | 19.62M | 19.99M |
| Year End June 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -2.54M | -5.26M | -6.06M | -7.03M | -4.32M |
| Investing | N/A | 2.98M | -412k | -292k | -175k |
| Financing | 2.31M | -49k | 16.88M | -268k | 5.91M |
| Market Cap | 109.21M |
| Price to Earnings Ratio | -7.41 |
| Price to Sales Ratio | 31.08 |
| Price to Cash Ratio | 5.26 |
| Price to Book Ratio | 2.43 |
| Dividend Yield | - |
| Shares Outstanding | 105.52M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.05 (4.19%) |
| Company Name | Bard1 Life Sciences Limited |
| Address |
23 normanby road melbourne, victoria 3168 |
| Website | https://www.bard1.com |
| Industry | finance services (6199) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
